Thought Leadership

Latest Report

Thumbnail

EvaluatePharma Orphan Drug Report 2019

$242bn forecasted orphan drug sales by 2024, one-fifth of the total worldwide pharmaceutical market The EvaluatePharma Orphan Drug Report 2019 arrives at the start of a new era the orphan drug industry, following the FDA’s approval of the first gene therapy product. Coupled with other breakthrough cell therapy products, the orphan drug market is…

Report library

Thumbnail

EvaluatePharma Orphan Drug Report 2018

Report Highlights Worldwide orphan drug sales are forecasted to grow at a CAGR of 11% from 2018-2024 The mean price of the top 100 USA orphan drugs is expected to…